Literature DB >> 27848249

Cystathionine γ-Lyase Deficiency Exacerbates CCl4-Induced Acute Hepatitis and Fibrosis in the Mouse Liver.

Lei Ci1, Xingyu Yang1, Xiaowen Gu1, Qing Li1,2, Yang Guo1, Ziping Zhou1, Mengjie Zhang1, Jiahao Shi1, Hua Yang1, Zhugang Wang2, Jian Fei1,2.   

Abstract

AIMS: The present study examined the role of cystathionine γ-lyase (CSE) in carbon tetrachloride (CCl4)-induced liver damage.
RESULTS: A CSE gene knock-out and luciferase gene knock-in (KI) mouse model was constructed to study the function of CSE and to trace its expression in living status. CCl4 or lipopolysaccharide markedly downregulated CSE expression in the liver of mice. CSE-deficient mice showed increased serum alanine aminotransferase and aspartate aminotransferase levels, and liver damage after CCl4 challenge, whereas albumin and endogenous hydrogen sulfide (H2S) levels decreased significantly. CSE knockout mice showed increased serum homocysteine levels, upregulation of inflammatory cytokines, and increased autophagy and IκB-α degradation in the liver in response to CCl4 treatment. The increase in pro-inflammatory cytokines, including tumor necrosis factor-alpha in CSE-deficient mice after CCl4 challenge, was accompanied by a significant increase in liver tissue hydroxyproline and α-smooth muscle actin and histopathologic changes in the liver. However, H2S donor pretreatment effectively attenuated most of these imbalances. INNOVATION: Here, a CSE knock-out and luciferase KI mouse model was established for the first time to study the transcriptional regulation of CSE expression in real time in a non-invasive manner, providing information on the effects and potential mechanisms of CSE on CCl4-induced liver injury.
CONCLUSION: CSE deficiency increases pro-inflammatory cytokines in the liver and exacerbates acute hepatitis and liver fibrosis by reducing H2S production from L-cysteine in the liver. The present data suggest the potential of an H2S donor for the treatment of liver diseases such as toxic hepatitis and fibrosis. Antioxid. Redox Signal. 27, 133-149.

Entities:  

Keywords:  carbon tetrachloride; hepatitis; hydrogen sulfide; liver fibrosis

Mesh:

Substances:

Year:  2017        PMID: 27848249     DOI: 10.1089/ars.2016.6773

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  5 in total

Review 1.  Hydrogen sulfide and hepatic lipid metabolism - a critical pairing for liver health.

Authors:  Julie J Loiselle; Guangdong Yang; Lingyun Wu
Journal:  Br J Pharmacol       Date:  2018-12-28       Impact factor: 8.739

2.  Protective effects of hydrogen sulfide on portal hypertensive vasculopathy in rabbits by activating AKT-NF-κB pathway.

Authors:  Chao Wang; Juan Han; Dong-Jian Li; Zhen Yang; Lin Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

Review 3.  Hydrogen: An Endogenous Regulator of Liver Homeostasis.

Authors:  Yaxing Zhang; Jingting Xu; Hongzhi Yang
Journal:  Front Pharmacol       Date:  2020-06-11       Impact factor: 5.810

Review 4.  Implications of hydrogen sulfide in liver pathophysiology: Mechanistic insights and therapeutic potential.

Authors:  Hai-Jian Sun; Zhi-Yuan Wu; Xiao-Wei Nie; Xin-Yu Wang; Jin-Song Bian
Journal:  J Adv Res       Date:  2020-05-17       Impact factor: 10.479

5.  Hydrogen Sulfide Protects Against Ammonia-Induced Neurotoxicity Through Activation of Nrf2/ARE Signaling in Astrocytic Model of Hepatic Encephalopathy.

Authors:  Xiaozhi Jin; Dazhi Chen; Faling Wu; Lei Zhang; Yu Huang; Zhuo Lin; Xiaodong Wang; Rui Wang; Lanman Xu; Yongping Chen
Journal:  Front Cell Neurosci       Date:  2020-10-22       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.